
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.66 | 4.66 | 0.00 |
Shares | 94.20 | 94.20 | 0.00 |
Other | 1.14 | 1.14 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 10.60 | 13.63 |
Price to Book | 1.35 | 2.00 |
Price to Sales | 0.94 | 1.35 |
Price to Cash Flow | 7.71 | 8.84 |
Dividend Yield | 3.82 | 3.12 |
5 Years Earnings Growth | 8.22 | 9.20 |
Name | Net % | Category Average |
---|---|---|
Industrials | 27.15 | 10.82 |
Financial Services | 19.37 | 20.38 |
Healthcare | 14.78 | 13.89 |
Consumer Defensive | 10.93 | 10.95 |
Basic Materials | 10.59 | 4.66 |
Consumer Cyclical | 6.12 | 8.34 |
Energy | 3.77 | 6.26 |
Technology | 3.77 | 12.44 |
Communication Services | 2.66 | 7.62 |
Real Estate | 0.85 | 3.99 |
Number of long holdings: 65
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 4.17 | 86.21 | -1.64% | |
Kemira Oyj | FI0009004824 | 3.48 | 19.28 | +3.16% | |
BAE Systems | GB0002634946 | 3.47 | 1,665.50 | -1.33% | |
Diageo | GB0002374006 | 3.46 | 2,177.0 | -0.09% | |
Roche Holding Participation | CH0012032048 | 3.07 | 261.90 | +1.67% | |
J&J | US4781601046 | 3.02 | 154.14 | -0.05% | |
Safran | FR0000073272 | 2.97 | 250.30 | +0.85% | |
Fresenius SE | DE0005785604 | 2.80 | 42.9000 | -0.60% | |
Novartis | CH0012005267 | 2.70 | 91.68 | +0.85% | |
FMC | US3024913036 | 2.64 | 38.22 | +3.89% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Tweedy, Browne Global Value | 4.45B | 8.57 | 7.17 | 4.92 | ||
Tweedy, Browne Value | 415.75M | 5.70 | 7.35 | 5.40 | ||
Tweedy, Browne Global Value II Ccy | 180.2M | -2.40 | 0.33 | 3.14 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review